Relationship of neuropsychological and MRI measures to age of onset of schizophrenia

Acta Psychiatrica Scandinavica

Volumn 98, Issue 2, 1998, Pages 156-164

  Jeste, D V ^a,b   McAdams, L A ^a   Palmer, B W ^a   Braff, D ^a   Jernigan, T L ^a   Paulsen, J S ^a   Stout, J C ^a   Symonds, L L ^a   Bailey, A ^a   Heaton, R K ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ageing; Antipsychotics; Brain imaging; Cognition; Learning; Psychosis

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGING; ARTICLE; COGNITION; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; STRESS;

EID: 14444281775     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1998.tb10058.x     Document Type: Article

References (68)

1. DELISI LE. The significance of age for onset of schizophrenia. Schizophr Bull 1992: 18: 209-215.
2. HARRIS MJ, JESTE DV. Late-onset schizophrenia: an overview. Schizophr Bull 1988: 14: 39-55.
3. CASTLE DJ, MURRAY RM. The epidemiology of late-onset schizophrenia. Schizophr Bull 1993: 19: 691-700.
4. MORRIS AG, GAITONDE E, MCKENNA PJ, MOLLON JD, HUNT DM. CAG repeat expansions and schizophrenia: association with disease in females with early age-at-onset. Hum Mol Genet 1995: 4: 1957-1961.
5. CROW TJ, DONE DJ. Age of onset of schizophrenia in siblings: a test of the contagion hypothesis. Psychiatry Res 1986: 18: 107-117.
6. SHAM PC, JONES P, RUSSELL A et al. Age of onset, sex, and familial psychiatric morbidity in schizophrenia: Camberwell Collaborative Psychosis Study. Br J Psychiatry 1995: 165: 466-473.
7. MAYER C, KELTERBORN G, NABER D. Age of onset in schizophrenia: relations to psychopathology and gender. Br J Psychiatry 1993: 162: 665-671.
8. JOHNSTONE EC, OWENS DGC, BYDDER GM, COLTER N, CROW TJ, FRITH CD. The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates. Psychol Med 1989: 19: 91-103.
9. YANG PC, LIU CY, CHIANG SQ, CHEN JY, LIN TS. Comparison of adult manifestions of schizophrenia with onset before and after 15 years of age. Acta Psychiatr Scand 1995: 91: 209-212.
10. DELISI L, HOFF A, SCHWARTZ J et al. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry 1991: 29: 159-175.
11. RAZ S, RAZ N. Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging. Psychol Bull 1990: 108: 93-108.
12. ASO M, KURACHI M, SUZUKI M, YUASA S, MATSUI M, SAITOH O. Asymmetry of the ventricle and age at the onset of schizophrenia. Eur Arch Psychiatry Clin Neurosci 1995: 245: 142-144.
13. CROW TJ, COLTER N, FRITH CD, JOHNSTONE EC, OWENS DGC. Developmental arrest of cerebral asymmetries in early onset schizophrenia. Psychiatry Res 1989: 29: 247-253.
14. JERNIGAN TL, ZISOOK S, HEATON RK, MORANVILLE JT, HESSELINK JR, BRAFF DL. Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry 1991: 48: 881-890.
15. HEATON R, PAULSEN J, MCADAMS LA et al. Neuropsychological deficits in schizophrenia: relationship to age, chronicity and dementia. Arch Gen Psychiatry 1994: 51: 469-476.
16. COREY-BLOOM J, JERNIGAN T, ARCHIBALD S, HARRIS MJ, JESTE DV. Quantitative magnetic resonance imaging in late-life schizophrenia. Am J Psychiatry 1995: 152: 447-449.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, revised 3rd edn. Washington, DC: American Psychiatric Press, 1987.
18. BRAFF DL, HEATON R, KUCK J et al. The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test Results. Arch Gen Psychiatry 1991: 48: 891-898.
19. SYMONDS LL. Lack of clinically significant abnormalities in MRIs of older patients with schizophrenia and related psychoses. 149th Annual Meeting of the American Psychiatric Association, 1996: 240.
20. JESTE DV, HARRIS MJ, KRULL A, KUCK J, MCADAMS LA, HEATON R. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am J Psychiatry 1995: 152: 722-730.
21. PALMER BW, HEATON RK, PAULSEN JS et al. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 1997: 11: 437-464.
22. SPITZER RL, WILLIAMS JBW. Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P). New York: Biometric Research Department, New York State Psychiatric Institute, 1986.
23. MAURER K, HAFNER H. Methodological aspects of onset assessment in schizophrenia. Schizophr Res 1995: 15: 265-276.
24. JESTE DV, SYMONDS LL, HARRIS MJ, PAULSEN JS, PALMER BW, HEATON RK. Non-dementia non-praecox dementia praecox? Late-onset schizophrenia. Am J Geriatr Psychiatry 1998: 5: 302-317.
25. SHROUT PE, FLEISS JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979: 86: 420-428.
26. OVERALL JE, GORHAM DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962: 10: 799-812.
27. ANDREASEN NC, OLSEN S. Negative vs. positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982: 39: 789-794.
28. National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). Early Clin Drug Eval Unit Intercom 1975: 4: 3-6.
29. JESTE DV, WYATT RJ. Understanding and treating tardive dyskinesia. New York: Guilford Press, Inc., 1982.
30. WYATT RJ, TORGON JS. A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders. J Psychiatr Res 1977: 13: 91-98.
31. REITAN RM, WOLFSON D. The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neuropsychology Press, 1985.
32. HEATON R, GRANT I, MATTHEWS C. Comprehensive norms for an expanded Halstead-Reitan battery. Odessa, FL: Psychological Assessment Resources, Inc., 1991.
33. HEATON RK. Comprehensive norms for an expanded Halstead-Reitan Battery: a supplement to the Wechsler Adult Intelligence Scale - Revised. Odessa, FL: Psychological Assessment Resources, Inc., 1992.
34. JERNIGAN TL, ARCHIBALD SL, BERHOW MT, SOWELL ER, FOSTER DS, HESSELINK JR. Cerebral structure on MRI. Part I. Localization of age-related changes. Biol Psychiatry 1991: 29: 55-67.
35. p. Technometrics 1973: 15: 661-665.
36. WEISBERG S. Applied linear regression. New York: John Wiley & Sons, 1980.
37. SAYKIN AJ, GUR RC, GUR RE et al. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry 1991: 48: 618-624.
38. BUCHANAN RW, BREIER A, KIRKPATRICK B et al. Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 1993: 150: 59-65.
39. BREIER A, BUCHANAN RW, ELKASHEF A, MUNSON RC, KIRKPATRICK B, GELLAD F. Brain morphology and schizophrenia: a magnetic resonance imaging study of the limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 1992: 49: 921-926.
40. SWAYZE VW, ANDREASEN NC, ALLIGER RJ, YUH WTC, EHRHARDT JC. Subcortical and temporal structures in affective disorders and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 1992: 31: 221-240.
41. HECKERS S, HEINSEN H, HEINSEN Y, BECKMANN H. Cortex white matter, and basal ganglia in schizophrenia: a volumetric postmortem study. Biol Psychiatry 1991: 29: 556-566.
42. RESNICK SM, GUR RE, ALAVI A, GUR RC, REIVICH M. Positron emission tomography and subcortical glucose metabolism in schizophrenia. Psychiatry Res 1988: 24: 1-11.
43. 15 positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet 1983: 2: 1448-1452.
44. VITA A, BRESSI S, PERANI D et al. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. Am J Psychiatry 1995: 152: 876-882.
45. KAWASAKI Y, SUZUKI M, MAEDA Y et al. Regional blood flow in patients with schizophrenia: a preliminary report. Eur Arch Psychiatry Clin Neurosci 1992: 241: 195-200.
46. SIEGEL BV, BUCHSBAUM MS, BUNNEY WE et al. Corticalstriatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry 1993: 150: 1325-1336.
47. GUENTHER W, BRODIE JD, BARTLETT EJ et al. Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study. Eur Arch Psychiatry Clin Neurosci 1994: 244: 115-125.
48. FRAZIER JA, GIEDD JN, HAMBURGER SD et al. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry 1996: 53: 617-624.
49. CHAKOS MH, LIEBERMAN JA, BILDER RM et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994: 151: 1430-1436.
50. KESHAVAN MS, BAGWELL WW, HAAS GL, SWEENEY JA, SCHOOLER NR, PETTEGREW JW. Changes in caudate volume with neuroleptic treatment (letter). Lancet 1994: 344: 1434.
51. CHAKOS MH, LIEBERMAN JA, ALVIR J, BILDER R, ASHTARI M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine (letter). Lancet 1995: 345: 456-457.
52. FRAZIER JA, GIEDD JN, KAYSEN D et al. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry 1996: 153: 564-566.
53. EARLY TS, REIMAN EM, RAICHLE ME, SPITZNAGEL EL. Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proc Natl Acad Sci USA 1987: 84: 561-563.
54. JESTE DV, LOHR JB, MANLEY M. Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats. Psychopharmacology 1992: 106: 154-160.
55. BAUMER H. Veränderungen des Thalamus bei Schizophrenie (Changes in the thalamus in schizophrenia). J Hirnforsch 1954: 157-172.
56. TREFF WM, HEMPEL KJ. Die Zelldichte bei Schizophrenen und klinisch Gesunden (Cell density in schizophrenia and control). J Hirnforsch 1958: 4: 314-369.
57. PAKKENBERG B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenia. Arch Gen Psychiatry 1990: 47: 1023-1028.
58. PAKKENBERG B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res 1992: 7: 95-100.
59. ANDREASEN NC, ARNDT S, SWAYZE VW et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994: 266: 294-298.
60. BUCHSBAUM MS, SOMEYA T, TENG CY et al. PET and MRI of the thalamus in never-medicaled patients with schizophrenia. Am J Psychiatry 1996: 153: 191-199.
61. ANDREASEN NC, EHRHARDT JC, SWAYZE VW et al. Magnetic resonance imaging of lhe brain in schizophrenia. Arch Gen Psychiatry 1990: 47: 35-44.
62. DUPONT RM, JERNIGAN TL, HEINDEL W et al. Magnetic resonance imaging and mood disorders. Localization of while mailer and other subcortical abnormalities. Arch Gen Psychiatry 1995: 52: 747-755.
63. FEINBERG I. Schizophrenia: caused by a fault in programmed synaptic climination during adolescence? J Psychiatr Res 1983: 17: 319-334.
64. WEINBERGER DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987: 44: 660-669.
65. KESHAVAN MS. Neurodevelopment and schizophrenia: quo vadis? In: KESHAVAN MS et al., ed. Neurodevelopment and adult psychopathology. Cambridge: Cambridge University Press, 1998: in press.
66. SULLIVAN EV, SHEAR PK, LIM KO, ZIPURSKY RB, PFEFFERBAUM A. Cognitive and motor impairments are related to gray matter volume deficits in schizophrenia. Biol Psychiatry 1996: 39: 234-240.
67. RUSSELL AJ, MUNRO JC, JONES PB, HEMSLEY DR, MURRAY RM. Schizophrenia and the myth of intellectual decline. Am J Psychiatry 1997: 154: 635-639.
68. SPOHN HE, STRAUSS ME. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 1989: 98: 367-380.